Amanote Research

Amanote Research

    RegisterSign In

Nrf2 Responses and the Therapeutic Selectivity of Electrophilic Compounds in Chronic Lymphocytic Leukemia

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1002890107
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

April 5, 2010

Authors
R. P. WuT. HayashiH. B. CottamG. JinS. YaoC. C. N. WuM. D. RosenbachM. CorrR. B. SchwabD. A. Carson
Publisher

Proceedings of the National Academy of Sciences


Related search

Refractory Chronic Lymphocytic Leukemia – New Therapeutic Strategies

Oncotarget
Oncology
2010English

Prognosis and New Therapeutic Approaches in Chronic Lymphocytic Leukemia Treatment

Medicinski podmladak
2019English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Chronic Lymphocytic Leukemia

Hematology/Oncology Clinics of North America
OncologyHematology
2004English

Chronic Lymphocytic Leukemia in Pregnancy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Lymphocyte Activation Gene 3: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Haematologica
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy